C. Tomasetti
Cancer Research · 2015–2022
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 36 citations into it; #738 of 1,780 by trust here, #733 by citations
- Genetics — 15 citations into it; #3,171 of 6,854 by trust here, #1,889 by citations
Whom C. Tomasetti trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts C. Tomasetti overall
Papers from C. Tomasetti's perspective
Ordered by how strongly the researchers C. Tomasetti trusts endorse each paper. Same corpus, a different order for every researcher.
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer (Science Translational Medicine)
- Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. (New England Journal of Medicine)
- Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. (Journal of Clinical Oncology)
- Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of… (Journal of Molecular Diagnostics)
- Epidermal homeostasis: a balancing act of stem cells in the skin (Nature reviews. Molecular cell biology)
- All you wanted to know about spermatogonia but were afraid to ask. (Journal of Andrology)
- Age-Associated Characteristics of Murine Hematopoietic Stem Cells (Journal of Experimental Medicine)
- Regulation of synaptic connectivity by glia (Nature)
- Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. (Journal of the National Cancer Institute)
- Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine (Nature Genetics)
Their papers
- Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer (2022) — 701 citations
- Detection and localization of surgically resectable cancers with a multi-analyte blood test (2018) — 2,397 citations
- Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention (2017) — 945 citations
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer (2016) — 1,312 citations
- Variation in cancer risk among tissues can be explained by the number of stem cell divisions (2015) — 1,504 citations